Across TCGA pan-cancer cohorts, CGB8 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated CGB8 data layer compared with 21 for mass-spec protein.
The strongest signal is observed in rectum adenocarcinoma (READ), where higher CGB8 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CGB8 expression acts as an unfavorable survival marker.
READ are the cancer types where CGB8 Mutation most reproducibly stratifies survival.